USA – Amwell, a Boston, MA-based national telehealth company, closed its Series C financing round, adding $194m in funding across two tranches.
Many early investors and strategic partners participated in this round, including Allianz X and Takeda. The company will use the funds to expand its investment in technology and services. Led by Ido Schoenberg, CEO, Amwell is a telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver access to care. The company offers a comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. Amwell powers telehealth solutions for over 240 health systems comprised of 2,000 hospitals and 55 health plan partners with over 36,000 employers. 21/05/2020
